Add time:07/21/2019         Source:sciencedirect.com

N-Chloroacetyl-5-bromoanthranilic acid (1), 3-[4′-(p-chlorophenyl)-thiazol-2′-yl]-2-chloromethyl-6-bromoquinazolin-4-one (2), 3-[4′-(p-chlorophenyl)-thiazol-2′-yl]-2-hydrazinomethyl-6-bromoquinazolin-4-one (3), 3-[4′-(p-chlorophenyl)-thiazol-2′-yl]-2-substitutedbenzylidene aminomethyl-6-bromoquinazolin-4-ones (4–11), 2-[(4′-oxo-3′-chloro-2′-phenylazetidin-1′-yl)aminomethyl]-3-[4″-(p-chlorophenyl)thiazol-2″-yl]-6-bromoquinazolin-4-ones (12–19) and 2-(4′-oxo-2′-phenyl-thiazolidin-3′-yl-aminomethyl)- 3-[4″-(p-chlorophenyl)-thiazol-2″-yl]-6-bromoquinazolin-4-ones (20–27) have been synthesized. All the compounds have been screened for their anti-inflammatory and analgesic activities at the dose of 50 mg/kg po. Compound 21 showed maximum anti-inflammatory (38.35%) and analgesic (37.36%) activities. Compound 21 was also tested for ulcerogenic activity and the UD50 value was found to be 195.6 mg/kg po. The structure of all compounds has been evaluated by elemental analysis (C, H, N) and spectral analysis (IR, 1H NMR and mass spectrometry).

We also recommend Trading Suppliers and Manufacturers of 5-(CHLOROMETHYL)-2-(4-CHLOROPHENYL)-4-METHYLOXAZOLE (cas 109544-39-0). Pls Click Website Link as below: cas 109544-39-0 suppliers